Table 1.
Role of MCs in the outcome of colorectal cancer.
| Publication | Disease stage | Methods of MCs identification | Localization | Prognosis |
|---|---|---|---|---|
| Mehdawi et al. (117) | All TNM stages | Tryptase and Chymase | Intratumoural/ peritumoural |
Positive |
| Elezoglu et al. (118) | All TNM stages | Toluidine blue | Intratumoural/ peritumoural |
Positive |
| Song et al. (22) | All TNM stages | Tryptase | Intratumoural/peritumoural | Positive |
| Xia et al. (59) | IIIB stage | Tryptase | Intratumoural/peritumoural | No relationship |
| Xia et al. (119) | All TNM stages | Tryptase and Chymase | Intratumoural/peritumoural | No relationship |
| Zhao et al. (120) | All TNM stages | Flow cytometric analysis | Intratumoural/peritumoural | No relationship |
| Zhao et al. (120) | All TNM stages | Flow cytometric analysis | Blood samples | Positive |
| Wu et al. (2) | All TNM stages | Tryptase | Intratumoural/peritumoural | Negative |
| Shinsuke et al. (121) | IV stage | Tryptase | Peritumoural | Negative |
| Malfettone et al. (122) | All TNM stages | Tryptase | Peritumoural | Negative |
| Mao et al. (123) | All TNM stages | CIBERSORT/Tryptase | Intratumoural/peritumoural | Negative |
| Gulubova et al. (124) | All TNM stages | Tryptase/Toluidine blue | Intratumoural/peritumoural | Negative |